CE Approved Covid-19 IgG/IgM Antibody Blood Test Kit can be used as an initial screening for qualitative and differential detection. Throughout testing the antibody of IgG and IgM immunoglobulins in human serum, plasma or blood, the test kit can show the result in a short time. Relative sensitivity 96.00%(192/200) Relative specificity 98.29%(806/820) Accuracy 97.84% (998/1020) Advantages Fast detection: 10 minutes to interpret the result; Easy to operate: no complex equipment required during test; Sensitive: the product has a higher sensitivity than PCR Nucleic Acid Global Network Singclean@COVID-19 lgG/gM Test Kit has been sold to more than 50 countries in the worid, like Brazil, Chie,Polandï¼?spain, Bolivia, Greece, Lihuania, Ecuador, Ukraine and Turkey. Precaution It is worth noting that the result of Covid-19 IgG/IgM antibody blood test should not be used as the only evidence of Coronavirus diagnosis. Professional doctors and clinical findings are necessary if the result of antibody test is positive. Besides, the test kit should be operated by professionals only. Use by individuals may cause deviation in test results. Limitation False negative and false positive could happen. If the antibody is lower than the detection level, especially in the 7 days of the onset of symptoms, a positive patient may also be diagnosed as negative.
CE Approved Singclean COVID-19Test Kit (Colloidal Gold Method) is a solid phase immunochromatographic assay for the rapid,qualitative detection of antigen from COVID-19 in human nasal swab specimen.This test provides only a preliminarytest result. Therefore, any reactive specimen with the COVID-19 Test Kit (Colloidal Gold Method) must be confimed with alternative testing method(s) and clinical findings. This rapid antigen test kit is the second test kit developed by Singclean Medical for COVID-19 testing on the basis of Colloidal Gold Method after Singclean COVID-19 lgG/IgM Test Kit, an antibody test, was launched globally in March. Advantage Results ready in 15 minutes Accurate diagnostic tool for active infection Easy to administer and read results Affordable, no need for instrument, highly portable Enable testing on a massive scale For healthcare workers use only Sensitivity 98.56% Sensitivity 99.03% Accuracy 98.84% Warnings 1. This test is not for at home testing, and should only be operated by healthcare workers. 2. Optimal assay performance requires strict adherence to the assay procedure described in this insert sheet. Inadequate or inappropriate sample collection, storage, and transport may cause false test results.
We Supple Grade A medical examination Disposable Covid-19 test kit and Syringes with affordable prices in major international market free to contact us for more Quotation.
We Supply Grade A medical examination Covid-19 Test Kit with affordable prices in major international market free to contact us for more Quotation.
We Supply Grade A medical examination Covid-19 Test Kit with affordable prices in major international market free to contact us for more Quotation.
Hello My name is Joe President of Blinq Wholesale supplier of Rapid Antigen Covid 19 test. We have 8m IHEALTH test available at our Los Angeles warehouse for $1.90 per test a box and it comes with the 6 month extension on the exp date till Jan 2023 We also have 10m Flowflex At $2.00 Per Box. All Units Are Here In The United States And Ready For Delivery. Price IS Negotiable as your quantity goes up. If you have any questions please email us
Due to contractual obligations to the federal government, Current suppliers have increased costs and limited production of all point of care tests without notice. We have great news! To shield our customers from excessive price increases as well as provide immediate availability, we have secured multiple FDA EUA rapid antigen test kit options. These tests have similar and/or better accuracy along with individual buffer bottles. We are currently able to provide three options: Clarity-Sienna, Indicaid and Celltrion DiaTrust kits. We work directly with the distributor and can supply by the pallet or case with pricing as low as $6.00 per kit.
CLIA Waived Use of this test with all authorized specimen types is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, that meet requirements to perform moderate or high complexity tests. This test is also authorized for use with fingerstick whole blood specimens only at the Point of Care (POC), i.e., in patient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation. The CLIA Waived COVID-19 IgG/IgM Rapid Test Device is an in vitro immunoassay for the direct and qualitative detection of anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG in human whole blood, serum, or plasma. The test is for professional use only. Indication: Qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in human venous whole blood (sodium EDTA), serum, or plasma (sodium EDTA). Intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. Emergency use of this test is limited to authorized laboratories. About Test Device EUA Authorized CE Mark Test does NOT give positive or negative result for COVID-19 virus. This is an antibody test, it only indicates past or recent infection. Read Results in 15 Minutes 9 Month Expiration from Date of Manufacture Contents 20 Test Devices 20 Disposable Pipettes 20 Alcohol Prep Pads Sterile Safety Lancets Buffer Package Insert
The CareStart COVID-19 Antigen Test is a lateral flow immunochromatographic assay intended for the qualitative detection of the nucleocapsid protein antigen from SARS-CoV-2 in nasopharyngeal or anterior nasal swab specimens directly collected from individuals who are either suspected of COVID-19 by their healthcare provider within the first five days of symptom onset or from individuals without symptoms or other epidemiological reasons to suspect COVID-19 when tested twice over two or three days with at least 24 hours and no more than 48 hours between tests. Testing is limited to laboratories certified under the Clinical Laboratory Improvement Amendments of 1988 (CLIA), 42 U.S.C. 263a, that meet the requirements to perform moderate, high, or waived complexity tests. This test is authorized for use at the Point of Care (POC), i.e., inpatient care settings operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation. Lateral flow assay Detect SARS-CoV-2 nucleocapsid protein antigen Rapid results within 10-15 minutes Intended at POC setting (i.e., in patient care settings) by medical professionals operating under a CLIA Certificate of Waiver, Certificate of Compliance, or Certificate of Accreditation For use under the Emergency Use Authorization (EUA) only For in vitro diagnostic use only For prescription use only For use with direct anterior nasal and nasopharyngeal swab specimens Clinical Performance 93.75% PPAa and 99.32% NPAb when used with nasopharyngeal swab 87.18% PPAa and 100% NPAb when used with anterior nasal swab
Master Carton - Contains 625 Tests For International Sale Only - Call for Pricing The COVID-19 IgG/IgM Rapid Test Device is an in vitro Immunoassay for the direct and qualitative detection of anti-SARS-CoV-2 IgM and anti-SARS-CoV-2 IgG in human whole blood, serum, or plasma. The test is for professional use only. Indication: Qualitative detection and differentiation of IgM and IgG antibodies to SARS-CoV-2 in human venous whole blood (sodium EDTA), serum, or plasma (sodium EDTA). Intended for use as an aid in identifying individuals with an adaptive immune response to SARS-CoV-2, indicating recent or prior infection. About Test Device Gives Positive or Negative Result for COVID-19 IgM/IgG antibodies Read Results in 15 Minutes Contents of each box 25 Test Devices 25 Disposable Pipettes 25 Alcohol Prep Pads Sterile Safety Lancets Buffer Package Insert
STANDARD M nCoV Real-Time Detection kit is used for rapid identification and detection of novel coronavirus (2019-nCoV) nucleic acids in human nasopharyngeal swabs and throat swab samples. - One tube reaction for identification and detection of 2019-nCoV - One-step Real-Time RT-PCR - Provide all reagents required for PCR - Designed according to WHO interim guidance for laboratory testing for 2019 novel coronavirus (2019-nCoV) in humans" - nCoV primers/probes ORF1ab (RdRp) gene, E gene Provide Internal controls Kindly check ghope-ppe.com. All information is for a consumer. If you want to buy a bulk, please contact us.
PPE COVID home test kit supply to worldwide. Shipping: CIF Payment: L/C MOQ: 100,000pcs
selling all ppe products from N95 masks KN95 masks masks 3ply masks gloves covid tests
